Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you
Continue to site >
Trending ETFs
Walgreens Boots company logo


Analyst Moves: UnitedHealth Group, AbbVie, Walgreens Boots Alliance, More (UNH, ABBV, WBA, More)

Before Monday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the most important analyst commentary for investors.

UnitedHealth Group Boosted to “Buy”

UnitedHealth Group (UNH ) has been upgraded from “Hold” to “Buy” at Jefferies as the company may increase market share in fast growing areas. UNH has a dividend yield of 1.26%.

BMO Capital Upgrades AbbVie

AbbVie (ABBV ) has been upgraded from “Market Perform” to “Outperform” at BMO Capital on a valuation call. ABBV has a dividend yield of 3.29%.

Citi Raises Estimates on Walgreens Boots Alliance

Citigoup has raised its price target on Walgreens Boots Alliance (WBA ) to $107. This new price target suggests a 16% increase from the stock’s current price. The firm boosted estimates on WBA due to higher expected growth. WBA has a dividend yield of 1.47%.

St. Jude Medical Upgraded to “Neutral”

St. Jude Medical Liquid error: internal has been upgraded from “Underperform” to “Neutral” at Credit Suisse as its business is expected gain momentum in the next year. STJ has a dividend yield of 1.70%.

Freeport-McMoRan Upgraded at Citi

Freeport-McMoRan (FCX ) has been boosted to “Buy” at Citigroup as analysts expect the copper market to improve by 2016. FCX has a dividend yield of 1.09%.